Follow the 비엘팜텍 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 비엘팜텍 has recorded 44 public disclosures. The latest transaction was filed on 21 January 2026 (Purchase). Among the most active insiders: 박영철. All data is openly available.
44
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
30 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
비엘팜텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.